Payment overview · 2025
General Payments
$46.17
2 reported records · 2 companies
Healthcare provider profile · identity verified
Laurie Beth Potratz
Allopathic & Osteopathic Physicians|Family Medicine · UNION GROVE, WI · NPI 1265894539
Verified facts
What the public records show
CMS Open Payments records show Laurie Beth Potratz received $46.17 in general payments during 2025 across 2 reported records.
Dynavax Technologies Corporation accounted for 55.8% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Dynavax Technologies Corporation | Unresolved — no canonical attribution shown | $25.76 | 55.8% | 1 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $20.41 | 44.2% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $46.17 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Heplisav-B Normalized: heplisav b |
Drug | Dynavax Technologies Corporation | $25.76 | 1 | 2025 |
Source payment records
|
|||||
| Cologuard Collection Kit Normalized: cologuard collection kit |
Device | Exact Sciences Corporation | $20.41 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 599 | 180 |
| Amlodipine Besylate | Amlodipine Besylate | 288 | 88 |
| Levothyroxine Sodium | Levothyroxine Sodium | 269 | 79 |
| Omeprazole | Omeprazole | 247 | 73 |
| Lisinopril | Lisinopril | 236 | 71 |
| Losartan Potassium | Losartan Potassium | 233 | 79 |
| Metoprolol Succinate | Metoprolol Succinate | 216 | 69 |
| Potassium Chloride | Potassium Chloride | 151 | 50 |
| Pantoprazole Sodium | Pantoprazole Sodium | 133 | 43 |
| Tamsulosin Hcl | Tamsulosin Hcl | 129 | 35 |
| Hydrochlorothiazide | Hydrochlorothiazide | 122 | 41 |
| Montelukast Sodium | Montelukast Sodium | 122 | 33 |
| Simvastatin | Simvastatin | 118 | 32 |
| Furosemide | Furosemide | 116 | 42 |
| Metformin Hcl | Metformin Hcl | 115 | 39 |
| Sertraline Hcl | Sertraline Hcl | 114 | 37 |
| Gabapentin | Gabapentin | 112 | 36 |
| Eliquis | Apixaban | 98 | 23 |
| Metoprolol Tartrate | Metoprolol Tartrate | 98 | 29 |
| Trazodone Hcl | Trazodone Hcl | 97 | 31 |
| Allopurinol | Allopurinol | 93 | 28 |
| Escitalopram Oxalate | Escitalopram Oxalate | 88 | 29 |
| Zolpidem Tartrate | Zolpidem Tartrate | 87 | 25 |
| Tramadol Hcl | Tramadol Hcl | 83 | 23 |
| Pravastatin Sodium | Pravastatin Sodium | 74 | 22 |
| Clopidogrel | Clopidogrel Bisulfate | 70 | 21 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 69 | 26 |
| Alprazolam | Alprazolam | 68 | 16 |
| Fluoxetine Hcl | Fluoxetine Hcl | 67 | 16 |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 64 | 64 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 62 | 27 |
| Meloxicam | Meloxicam | 62 | 21 |
| Duloxetine Hcl | Duloxetine Hcl | 61 | 17 |
| Alendronate Sodium | Alendronate Sodium | 58 | 15 |
| Jardiance | Empagliflozin | 58 | 14 |
| Ozempic | Semaglutide | 57 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 56 | 17 |
| Warfarin Sodium | Warfarin Sodium | 56 | 18 |
| Carvedilol | Carvedilol | 54 | 16 |
| Xarelto | Rivaroxaban | 54 | 14 |
| Buspirone Hcl | Buspirone Hcl | 53 | 12 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 51 | 22 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 49 | 15 |
| Glipizide Er | Glipizide | 44 | 11 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 44 | 14 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 43 | 19 |
| Bupropion Xl | Bupropion Hcl | 42 | suppressed |
| Cephalexin | Cephalexin | 42 | 21 |
| Glipizide | Glipizide | 42 | 15 |
| Lorazepam | Lorazepam | 42 | 20 |
| Donepezil Hcl | Donepezil Hcl | 41 | 12 |
| Finasteride | Finasteride | 40 | 12 |
| Metformin Hcl Er | Metformin Hcl | 40 | suppressed |
| Atenolol | Atenolol | 39 | 12 |
| Mirtazapine | Mirtazapine | 38 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 38 | 11 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 37 | suppressed |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 36 | 28 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 34 | suppressed |
| Memantine Hcl | Memantine Hcl | 34 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 34 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 33 | 17 |
| Spironolactone | Spironolactone | 32 | suppressed |
| Irbesartan | Irbesartan | 31 | suppressed |
| Clonazepam | Clonazepam | 30 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 30 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 29 | 11 |
| Hydralazine Hcl | Hydralazine Hcl | 29 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 28 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 27 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 26 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 26 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 25 | suppressed |
| Boostrix Tdap | Diphth,pertuss(Acell),tet Vac | 25 | 25 |
| Valacyclovir | Valacyclovir Hcl | 24 | 14 |
| Amoxicillin | Amoxicillin | 23 | 11 |
| Nystatin | Nystatin | 23 | 14 |
| Synthroid | Levothyroxine Sodium | 23 | suppressed |
| Trulicity | Dulaglutide | 23 | suppressed |
| Bumetanide | Bumetanide | 22 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 22 | suppressed |
| Famotidine | Famotidine | 22 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 22 | 11 |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 22 | suppressed |
| Ondansetron Odt | Ondansetron | 22 | suppressed |
| Pregabalin | Pregabalin | 22 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 22 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 21 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 21 | suppressed |
| Celecoxib | Celecoxib | 20 | suppressed |
| Ibuprofen | Ibuprofen | 20 | suppressed |
| Myrbetriq | Mirabegron | 19 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 19 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 19 | suppressed |
| Ezetimibe | Ezetimibe | 18 | suppressed |
| Prednisone | Prednisone | 18 | 13 |
| Sumatriptan Succinate | Sumatriptan Succinate | 17 | suppressed |
| Estradiol | Estradiol | 16 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 16 | suppressed |
| Semglee (Yfgn) Pen | Insulin Glargine-Yfgn | 16 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 16 | suppressed |
| Aripiprazole | Aripiprazole | 15 | suppressed |
| Azithromycin | Azithromycin | 15 | 14 |
| Betamethasone Valerate | Betamethasone Valerate | 15 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 15 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 15 | suppressed |
| Klor-Con M20 | Potassium Chloride | 15 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 15 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 15 | suppressed |
| Torsemide | Torsemide | 15 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 15 | 13 |
| Amitriptyline Hcl | Amitriptyline Hcl | 14 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 14 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 14 | suppressed |
| Scopolamine | Scopolamine | 14 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 13 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 13 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 13 | suppressed |
| Latanoprost | Latanoprost | 13 | suppressed |
| Captopril | Captopril | 12 | suppressed |
| Levetiracetam | Levetiracetam | 12 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 12 | suppressed |
| Temazepam | Temazepam | 12 | suppressed |
| Trihexyphenidyl Hcl | Trihexyphenidyl Hcl | 12 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 11 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 11 | suppressed |
| Cefpodoxime Proxetil | Cefpodoxime Proxetil | 11 | suppressed |
| Chlorthalidone | Chlorthalidone | 11 | suppressed |
| Dulera | Mometasone/Formoterol | 11 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 11 | suppressed |
| Fluconazole | Fluconazole | 11 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $46.17 · 2 records | Dynavax Technologies Corporation | Cologuard Collection Kit, Heplisav-B | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error